<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Immune response to Plasmodium falciparum liver stage antigen-1 : geographical variations within Central Africa and their relationship with protection from clinical malaria</dc:title>
  <dc:creator>Migot Nabias, F.</dc:creator>
  <dc:creator>/Deloron, Philippe</dc:creator>
  <dc:creator>/Ringwald, Pascal</dc:creator>
  <dc:creator>Dubois, B.</dc:creator>
  <dc:creator>Mayombo, J.</dc:creator>
  <dc:creator>Minh, T.N.</dc:creator>
  <dc:creator>/Fievet, Nadine</dc:creator>
  <dc:creator>Millet, P.</dc:creator>
  <dc:subject>PALUDISME</dc:subject>
  <dc:subject>IMMUNOLOGIE</dc:subject>
  <dc:subject>ENFANT D'AGE SCOLAIRE</dc:subject>
  <dc:subject>VACCINATION</dc:subject>
  <dc:subject>ANTIGENE</dc:subject>
  <dc:subject>TEST ELISA</dc:subject>
  <dc:subject>ANTICORPS</dc:subject>
  <dc:subject>ANALYSE STATISTIQUE</dc:subject>
  <dc:subject>ETUDE REGIONALE</dc:subject>
  <dc:subject>ETUDE COMPARATIVE</dc:subject>
  <dc:subject>LSA1.LIVER STAGE ANTIGEN 1</dc:subject>
  <dc:subject>TNF ALPHA.TUMOR NECROSIS FACTOR ALPHA</dc:subject>
  <dc:subject>IFN GAMMA.INTERFERON GAMMA</dc:subject>
  <dc:subject>IL10.INTERLEUKIN 10</dc:subject>
  <dc:subject>LPA.LYMPHOCYTE PROLIFERATIVE ASSAY</dc:subject>
  <dc:subject>CYTOKINE</dc:subject>
  <dc:subject>CELLULE T</dc:subject>
  <dc:description>Two populations of schoolchildren from Gabon and Cameroon were tested in 1995 for their immunological reactivity to synthetic peptides (LSA-Rep, LSA-J and LSA-CTL) from Plasmodium falciparum liver stage antigen-1 (LSA-1). The prevalence and levels of both cellular (lymphocyte proliferation, tumour necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma), and interleukin-10 (IL-10)) and humoral (immunoglobulin G) responses were determined. Protection from clinical malaria, determined after a prospective 1 year study in both sites, was associated with elevated proliferative responses to LSA-Rep and LSA-CTL in the Gabonese children, as well as with higher antibody levels to both schizont extract and LSA-Rep. The prevalence of peptide-stimulated TNF-alpha secretion was higher in the Cameroonian group, but higher levels of antibodies to LSA-Rep and LSA-J were found in the Gabonese children. The immunological differences observed between children in the 2 study sites are discussed in the context of both epidemiological and individual host factors. (R&#xE9;sum&#xE9; d'auteur)</dc:description>
  <dc:date>2000</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010024068</dc:identifier>
  <dc:identifier>fdi:010024068</dc:identifier>
  <dc:identifier>Migot Nabias F., Deloron Philippe, Ringwald Pascal, Dubois B., Mayombo J., Minh T.N., Fievet Nadine, Millet P.. Immune response to Plasmodium falciparum liver stage antigen-1 : geographical variations within Central Africa and their relationship with protection from clinical malaria. 2000, 94 (5),  557-562</dc:identifier>
  <dc:language>EN</dc:language>
  <dc:coverage>CAMEROUN</dc:coverage>
  <dc:coverage>GABON</dc:coverage>
</oai_dc:dc>
